AI Telehealth & Remote Care 2026 Complete Guide - Teladoc, Amwell, Hims & Hers, Ro, K Health, DoctorNow, Goodoc, Ttocdoc, Linkx, LINE Healthcare, MedPeer Deep Dive

Prologue — Telehealth Enters Its Mature Phase in 2026

The COVID-19 pandemic in March 2020 thrust telehealth into the mainstream overnight. The US CMS (Centers for Medicare and Medicaid Services) lifted Medicare telehealth restrictions on a temporary basis as of March 17, 2020, Korea allowed temporary non-face-to-face care on February 24, 2020, and Japan allowed online consultations from a first visit on April 2, 2020.

Six years later, in May 2026, those temporary measures have either become permanent or been partly rolled back. The US Medicare telehealth extension nearly expired in March 2025 but Congress extended it to September 2025, and then a second extension carried it to September 2026. Korea moved from a pilot program in June 2023 to a December 2024 partial amendment of the Medical Service Act, centering on chronic-disease management and follow-up care. Japan elevated its online consultation guidelines to a main provision in January 2022 and put online prescriptions into effect in April 2023.

A one-sentence snapshot of telehealth as of May 2026:

US legacy telehealth — Teladoc, Amwell, MDLive, and Included Health captured the payer and employer channels, and the center of gravity shifted to chronic-disease care.
US DTC telehealth — Hims & Hers, Ro, K Health, and Sesame grew the cash market that bypasses insurance, with compounded GLP-1s exploding in 2024.
AI medical scribes — Abridge, Suki, and Microsoft Nuance DAX Copilot cut physician note-writing time from 2-3 hours a day to 30 minutes.
Korean non-face-to-face care — DoctorNow, Goodoc, and Ttocdoc run on top of the pilot program, focused on chronic and follow-up care, but drug delivery remains restricted.
Japanese online care — Linkx (Doctors Mobile), LINE Healthcare, CLINIC FOR, MedPeer, kakari, and Curon are growing together after online prescriptions took effect.
EU telehealth — Doctolib (France, Germany) and KRY/Livi (Sweden, Norway, UK) split the market, while one-time unicorn Babylon Health went bankrupt in the UK in 2023.

This essay ties together the pricing, clinical evidence, regulation, and real usage scenarios of those 70-plus services in a single flow.

Chapter 1 · Why Telehealth Did Not Work Before 2020

Telehealth existed for more than 30 years before COVID-19. NASA tried it in 1989 for astronaut medicine, and military medics used satellite links for remote consultations in the 1990s. It failed to spread to ordinary citizens for three reasons.

No insurance reimbursement — US Medicare recognized telehealth from 1997 but only in rural HPSAs (Health Professional Shortage Areas). Telehealth billing for urban patients on Medicare was effectively impossible.
State-by-state physician licensing — US physicians must be licensed in each state where they see patients. A California physician seeing a Texas patient needed a separate Texas license.
HIPAA compliance burden — Video tools had to be HIPAA-compatible, and before 2019 it was costly and technically demanding for general practitioners to set up HIPAA-compliant Zoom.

In March 2020, CMS lifted all three at once with the 1135 Waiver. Medicare recognized urban patients, state license limits were temporarily lifted, and non-HIPAA Zoom, FaceTime, and Skype were allowed. Telehealth claims grew 154-fold in a single month in April 2020 (HHS OIG report).

Korea moved from temporary permission on February 24, 2020 to a pilot program in June 2023 and the December 2024 amendment of the Medical Service Act. Japan moved consistently: first-visit allowance on April 2, 2020, main-provision elevation in January 2022, and online prescriptions in April 2023.

[Telehealth evolution timeline — 2020-2026]
  2020-03  US CMS 1135 Waiver, Korea emergency allowance, Japan first-visit allowance
  2020-08  Teladoc + Livongo merger announced ($18.5B)
  2021-01  Hims & Hers SPAC IPO (NYSE:HIMS)
  2021-05  Cerebral Series C ($1.5B valuation), ADHD prescriptions explode
  2022-01  Japan online consultation main-provision elevation
  2022-04  Done. DOJ investigation, Cerebral DEA investigation begins
  2023-04  Japan online prescription enforcement
  2023-06  Korea non-face-to-face care pilot launches
  2023-08  Babylon Health UK subsidiary goes bankrupt
  2024-04  Hims & Hers compounded GLP-1 launch
  2024-12  Korea Medical Service Act amendment (chronic & follow-up expansion)
  2025-09  US Medicare telehealth extension (to 2026-09)

Chapter 2 · The US Telehealth Leader — Teladoc Health (NYSE:TDOC)

Teladoc Health (teladochealth.com) was founded in Texas in 2002 and is the largest US telehealth company. It went public on NYSE in July 2015. As of May 2026, its market cap is about $1.7 billion, down roughly 95 % from its 2021 peak of$ 308.

August 2020 — Acquired Livongo Health for $18.5 billion, entering chronic-disease management (diabetes, hypertension).
December 2020 — Acquired InTouch Health, gaining in-hospital telehealth carts.
Q2 2022 — Booked a $13.88 billion goodwill impairment on Livongo, the decisive trigger of the stock collapse.
April 2023 — CEO Jason Gorevic resigned. Mala Murthy served as interim, and Chuck Divita took over formally in June 2024.
March 2024 — Cost cuts at BetterHelp (acquired 2015) as revenue growth slowed.
Q1 2025 — Acquired Catapult Health (preventive care), reshaping the portfolio yet again.

Pricing is dominated by payer and employer channels. One-off visits paid out of pocket cost about $75, and the BetterHelp mental health subscription runs$ 65-100 per week.

Teladoc's core asset is chronic-disease management. The Livongo-integrated diabetes and hypertension devices (BG meters, BP monitors) and data platform together remain the largest chronic-care pool in US telehealth in 2026.

Chapter 3 · Amwell (American Well) — Hospital Partnership Pivot

American Well (americanwell.com, NYSE:AMWL) was founded in Boston in 2006 by brothers Roy and Ido Schoenberg. It went public on NYSE in September 2020, raising about $700 million.

Q1 2021 — Peak market cap around $8 billion, then a steady decline to about$ 200 million by May 2026.
2022-2023 — Strengthened white-label partnerships with major hospitals like Cleveland Clinic and Intermountain Healthcare.
Q1 2023 — Converge platform integration completed, bundling AI-based triage and note tools.
Q2 2024 — Won a $500 million contract with the US Defense Health Agency (DOD), the foundation for military telehealth.
Q4 2025 — Conversa Health (automated patient interaction) integration narrows EBITDA losses.

Amwell's strategy diverges from Teladoc's. Teladoc tried to capture both B2C (direct to patient) and B2B2C (through payers), while Amwell chose to be the white-label infrastructure for hospitals and health systems. So the "Amwell" brand is weak with ordinary consumers, but over 100 US health systems use Amwell as the back end for their patient apps.

Chapter 4 · MDLive (Cigna Evernorth) — Payer Integration

MDLive (mdlive.com) is one of the earliest US telehealth firms, founded in the late 1990s and acquired by Cigna's Evernorth subsidiary for about $500 million in April 2021. Since then, MDLive has been integrated as the digital health channel for Cigna Healthcare members rather than as a standalone telehealth brand.

Automatic Cigna member access — Cigna members get MDLive visits at no extra cost.
Primary categories — General care, mental health, dermatology, urology.
HSA/FSA payment — Employer-insurance integration minimizes administrative overhead.

MDLive's value is being "the most cleanly payer-integrated telehealth." Surviving as a standalone brand was hard in the early 2020s, but inside Cigna it has the cleanest infrastructure for simplifying payment, billing, and automatic enrollment.

Chapter 5 · Doctor on Demand + Grand Rounds → Included Health

Included Health (includedhealth.com) was born in March 2021 from the merger of Doctor on Demand and Grand Rounds Health. Both companies had been founded in the early 2010s.

Doctor on Demand (2012, San Francisco) — Video care, founded by Adam Jackson.
Grand Rounds (2011, San Francisco) — Medical navigation (second opinions, specialist matching), founded by Owen Tripp.
After the merger — First named "Doctor on Demand + Grand Rounds," then unified as "Included Health" in September 2021.
February 2022 — Acquired Walmart Health Virtual Care, strengthening the large-employer channel.
Positioning — Integrated "Care Navigation + Virtual Primary Care + Behavioral Health + Specialty Care."

Included Health's differentiator is medical navigation. In the US system, deciding "which specialist to see and where" is surprisingly hard. The Grand Rounds legacy lives on in automating that matching and second-opinion service.

Chapter 6 · Hims & Hers Health (NYSE:HIMS) — Exploded on GLP-1

Hims & Hers Health (hims.com, forhers.com) was founded by Andrew Dudum in November 2017 and is the flagship of DTC (direct-to-consumer) telehealth.

November 2017 — Hims launched for men (hair loss, erectile dysfunction).
2018 — Hers launched for women (skin, hair, contraception).
January 2021 — IPO via SPAC (Oaktree Acquisition Corp) on NYSE, starting at about $1.6 billion market cap.
September 2022 — Mental Health category launched (SSRIs, psychiatric prescriptions).
April 2024 — Compounded semaglutide launched at $199 a month. Quarterly revenue doubled.
Q4 2025 — Revenue around $1.8 billion (annualized), market cap topped$ 10 billion.
Q1 2026 — Acquired Lustgarten (blood-testing clinics), bundling labs, visits, and meds in one app.

What sets Hims & Hers apart is "not going through insurance." It simplifies prices in the cash market and ships medications directly. The April 2024 compounded GLP-1 launch (503A pharmacies filling the Eli Lilly and Novo Nordisk shortage) doubled revenue, but the legal foundation for compounding shook when the FDA declared the semaglutide shortage resolved in October 2024.

In April 2025, it signed a direct supply deal with Novo Nordisk to shift to legitimate Wegovy prescriptions, and prices were partially raised from $199.

Chapter 7 · Ro (Roman + Plenity + Modern Fertility) — Men's Full Stack

Ro (ro.co, originally Roman Health) was founded in 2017 by Zachariah Reitano, Saman Rahmanian, and Rob Schutz. It began as a single-line tele-ED (erectile dysfunction) business under the Roman brand.

2017 — Roman launched. Tele-ED.
2019 — Rory launched (women's menopause, hair).
2020 — Acquired Plenity (weight management device).
2021 — Acquired Modern Fertility (women's reproductive hormone testing).
2024 — Compounded GLP-1 launched, mirroring Hims.
2025 — Ro Body launched as a comprehensive weight-management channel.

Ro is private (not listed). It reached a $7 billion valuation in March 2022 with a$ 1.4 billion Series D, but value wobbled after intensifying GLP-1 competition and compounding regulatory risk.

Ro's strength is the depth of its men's market. The Roman brand works as a comprehensive male primary-care channel from ED to hair loss to cholesterol to diabetes.

Chapter 8 · K Health — AI Symptom Checker Plus GP

K Health (khealth.com) was founded in 2016 in Tel Aviv, Israel, by Allon Bloch and co-founders. It is dual-headquartered in the US and Israel.

AI symptom checker — Trained on 25 years of anonymized data from Israel's Maccabi Healthcare Services (20 million patients).
**Free app + $49-99 visits** — Free AI primary triage,$ 49 doctor chat, $99 video.
2021 — Mayo Clinic partnership. Affiliated clinicians use it.
2022 — Cedars-Sinai partnership.
2023 — Integration with Anthem Blue Cross Blue Shield and affiliated payers.
2024 — Added a GLP-1 line.

K Health's core is that the AI symptom checker is a diagnostic model, not a simple chatbot. Patient symptom input → statistical match to past patients of the same symptoms, age, and sex → primary triage handed to the physician. The company claims it cuts average physician visit time in half.

Chapter 9 · Sesame — Flat-Rate Marketplace

Sesame (sesamecare.com) was founded by David Goldhill and Michael Botta in 2018 with the motto "see a doctor at a reasonable price even without insurance."

Flat rates — General visits $35-65, psychiatry$ 75-150, labs and imaging separate.
Cash only — No insurance billing. HSA and FSA are eligible.
Marketplace model — Sesame matches rather than employs physicians, much like Uber's structure.
CostPlus Drugs integration (2023) — Mark Cuban's pharmacy integration cuts prescription prices.

Sesame's value is price transparency. It shows the biggest pain point of US healthcare — "you don't know how much it will cost" — on the first screen. Without insurance reconciliation, there is also less retrospective-billing risk for physicians.

Chapter 10 · PlushCare (Accolade), Talkiatry, Cerebral — Specialty Branching

While legacy telehealth tried to capture all of primary care, the mid-2020s saw branching into specialties.

PlushCare — Founded 2014, primary care and mental health. Acquired by Accolade (NASDAQ:ACCD) for about $400 million in 2021.
Talkiatry (talkiatry.com) — Founded 2020, psychiatry only, in-network insurance billing. Series C $130 million (2024).
Cerebral (cerebral.com) — Founded 2020, mental health. Explosive ADHD prescribing in 2022, then DEA and DOJ investigations. Reached a $2.2 billion settlement in 2024 over controlled substances and Adderall.
Done. — DTC ADHD care. Stopped Adderall prescribing after the 2022 DEA investigation.

Cerebral and Done. illustrate the regulatory gray zone of telehealth. Remote prescribing of controlled substances (Schedules II, III, IV) was originally governed by the 1973 Ryan Haight Act with an in-person-visit requirement, temporarily lifted during COVID. The DEA Final Rule in November 2025 made some of that permanent, but ADHD medications remain under strict limits.

Chapter 11 · Mental Health Telehealth — Talkspace, BetterHelp, Lyra, Spring, Headspace, Brightline

Mental health is the category where telehealth works best. No stethoscope or labs are needed, and conversation is the substance of care.

Talkspace (NASDAQ:TALK) — Founded in 2012 by an Israeli couple, IPO via SPAC in 2021. Messaging, voice, and video tiers, with strengthened insurance integration.
BetterHelp — Founded 2013, acquired by Teladoc in 2015. $65-100 per week. Revenue slowdown in 2023-2024.
Lyra Health — Founded 2015, B2B only. Series G at about a $6 billion valuation (2024). Big employers include Morgan Stanley and Starbucks.
Spring Health — Founded 2016, B2B. Series E at $3.3 billion valuation (2024).
Headspace Health — 2021 merger of Ginger and Headspace, blending B2C meditation with B2B mental health.
Brightline — Founded 2019, pediatric and adolescent focus. Series C $100 million (2022).
Octave — Founded 2018, couples therapy. Series C $52 million.
Two Chairs (twochairs.com) — Founded 2017, blends in-person and remote.

The 2024-2025 trend shifted from B2C to B2B (employer insurance). Employees get free sessions through their EAP (Employee Assistance Program), then continue with insurance-billed care. Lyra and Spring are the two leaders in that space.

Chapter 12 · AI Medical Scribes — Abridge, Suki, Microsoft Nuance DAX

Physicians spending 30 minutes to two hours per visit on charting was the biggest cost and burnout source in US medicine. From 2023, LLM-based AI scribes cut that time by 90 %.

Abridge (abridge.com) — Founded in Pittsburgh in 2018 by Dr. Shiv Rao. Series D $150 million (2024), Series E$ 250 million (2025) at $2.5 billion valuation. Deep Epic Systems integration.
Suki AI (suki.ai) — Founded 2017 by Punit Soni. Series D $70 million (2024). Step-by-step voice notes.
DeepScribe (deepscribe.ai) — Founded 2017. Consent-based voice capture.
Augmedix (NASDAQ:AUGX) — Founded 2012, SPAC IPO in 2021. Hybrid human-and-AI scribe model.
Microsoft Nuance DAX Copilot — Microsoft acquired Nuance Communications for $19.7 billion in April 2022. DAX (Dragon Ambient eXperience) Copilot went GA in September 2023. Deep integration with Epic, the US healthcare EMR leader.
Ambience Healthcare — Founded 2020. Series C $70 million (2024).
Nabla (nabla.com) — Paris, France. Used by 5,000 physicians at Permanente Medical Group. Series B $24 million (2024).
Tali AI — Canada. Multilingual support (English, French, Spanish).

The differentiator for scribes is EMR-integration depth. Abridge runs deepest with Epic, Suki with Cerner and Athenahealth, and DAX Copilot has the deepest Epic integration. Physicians do not press a separate button during the visit — the recording happens in the background, the note is auto-generated, and a single click inserts it into the Epic chart.

Chapter 13 · Chronic Care Management — Omada, Livongo, Virta, Vida, Cecelia

Chronic-disease management is the highest cost-per-patient category in healthcare. A single diabetes, hypertension, or heart-failure patient costs over $10,000 a year.

Omada Health (omadahealth.com) — Founded in San Francisco in 2011. CDC-certified Diabetes Prevention Program (DPP), employer-insurance channel. IPO filed in 2024, still pending as of May 2026.
Livongo (Teladoc subsidiary) — Merged with Teladoc for $18.5 billion in 2020. Diabetes, hypertension, weight management with BG- and BP-meter data.
Virta Health (virtahealth.com) — Founded 2014. Ketogenic-diet-based type 2 diabetes reversal. Series E at $1.2 billion valuation.
Cecelia Health — Founded 2009. Diabetes and cardiovascular phone-and-text coaching.
Vida Health — Founded 2014. Integrated chronic care. Series D $110 million.

The ROI calculation is simple. If a patient avoids one emergency room visit, $5,000-10,000 is saved. Coaching at$ 100 a month for a year is $1,200. The return profile is clear from a payer or employer point of view.

Chapter 14 · Korean Non-Face-to-Face Care — DoctorNow, Goodoc, Ttocdoc, Nemoya Doctor

Korean non-face-to-face care started on February 24, 2020 as a temporary allowance. It was upgraded to a pilot in June 2023, and the December 2024 Medical Service Act amendment cemented chronic-disease management and follow-up care.

DoctorNow (doctornow.kr) — Founded in 2019 by Seoyeon Park and Jiho Jang. Series B around 40 billion KRW (2022). The non-face-to-face leader. Built an integrated service of prescription issuance, drug delivery, and neighborhood pharmacy matching after joining the pilot in August 2023.
Goodoc (goodoc.co.kr) — Founded in 2012 under Yello Mobile, originally a clinic-search service. Expanded to COVID-19 vaccine and testing matching in 2020, joined non-face-to-face care in 2023.
Ttocdoc (ttocdoc.com) — Founded by Vibros in 2017. The leader in pediatric clinic appointment booking. Joined non-face-to-face care in 2023, integrating booking, telehealth, and prescription.
Nemoya Doctor — Operated by MediHere. Primary care and chronic-disease management.
MediHere (medihere.co.kr) — Founded in 2018. Early participant in the pilot program along with DoctorNow.
OllaCare (ollacare.com) — Founded in 2021. Operated by Life Smith.

The key points of the December 2024 amendment of the Medical Service Act:

Follow-up focus — Initial visits are face-to-face in principle. Follow-ups with the same physician for the same condition can be non-face-to-face.
Chronic diseases — Eleven chronic conditions including hypertension and diabetes can be partly handled as non-face-to-face initial visits.
Drug delivery — Still in pilot mode. Full operation is blocked by pharmacist association opposition.
Reimbursement — Non-face-to-face care is reimbursed at 130 % of face-to-face rates.

The biggest unresolved issue in May 2026 is drug delivery. Unlike in Japan and the US, mailing prescription drugs is hard in Korea because of pharmacist association opposition. Patients still visit a pharmacy in person or get neighborhood-pharmacy matching with a quick-courier delivery.

Chapter 15 · Japanese Online Consultation — Linkx, LINE Healthcare, CLINIC FOR, MedPeer

Japan has moved through consistent step-by-step expansion, unlike Korea and the US. The April 2018 introduction of online-consultation reimbursement was followed by the April 2020 COVID-era expansion, the January 2022 main-provision elevation, and the April 2023 introduction of online prescriptions.

Linkx (linkx.co.jp, operated by Doctors Mobile) — Founded in 2017 under Doctors Mobile. Anonymous chat consultation plus video visits with integrated drug delivery.
LINE Healthcare (line-healthcare.com) — Founded in 2019 by LINE Corporation and M3, integrated with LINE Messenger.
CLINIC FOR (clinicfor.life) — Founded in 2018. DTC video visits for obesity drugs, hair loss, and skin care.
MedPeer (medpeer.co.jp) — Founded in 2004. A doctor SNS with 140,000 Japanese physicians, plus B2C telehealth.
kakari (kakari.medpeer.jp) — MedPeer's patient app for prescriptions and medication management.
Curon (curon.co, operated by MICIN) — Founded in 2015. Patient-facing video visit app. Integrated with online prescriptions in 2023.
CLINICS (clinics.medley.life, operated by Medley) — Founded in 2014. Integrated physician EMR plus patient app.
Pocket Doctor — Operated by MRT. Video visits.

The April 2023 introduction of online prescriptions was a turning point. Until then, a patient who saw a doctor on video still had to visit a pharmacy or clinic to pick up a paper prescription. After enforcement, electronic prescriptions are sent directly to pharmacies and integrated into the patient's My Number Portal.

The differentiator in Japan compared with Korea and the US is the depth of physician-centric SNS networks. MedPeer has 140,000 members, and M3 Career has over 300,000. With patient and physician apps under one roof, there is less friction in prescription, billing, and booking.

Chapter 16 · European Telehealth — Doctolib, KRY/Livi, Babylon Health

Europe is yet another picture compared with the US and Asia. It is not a single market but the EU's 27 countries — a single market in many respects, but healthcare remains national sovereign territory. Within that, two companies took large positions.

Doctolib (doctolib.fr, doctolib.de) — Founded in Paris in 2013 by Stanislas Niox-Château. Booking integrated with telehealth. 40,000 clinics in France, 10,000 in Germany. Series H of €550 million (about $6 billion valuation) in 2022 after expansion to Italy.
KRY (kry.se, marketed as Livi in English-speaking markets) — Founded in Stockholm in 2014. The UK brand is Livi, with the NHS GP at Hand partnership.
Babylon Health — Founded in London in 2013. AI symptom checker plus video visits. After a NYSE IPO, its UK subsidiary went bankrupt in August 2023 and its US subsidiary was wound down. One-time symbol of UK telehealth, brought down by NHS contract disputes and a failed US expansion.
Push Doctor — Founded in the UK in 2013. GP non-face-to-face care.
Klara — Germany and the US. Secure patient-physician messaging.

Doctolib's strength is integrating booking and care. A patient searches a clinic and books, and the booking converts automatically into a video visit when needed. Deep EMR integration creates strong physician lock-in.

The Babylon bankruptcy illustrates the difficulty of the telehealth business. After a SPAC IPO in 2021 with a $3.6 billion market cap, NHS GP at Hand revenue-recognition disputes and a failed US push effectively wound the company down in 18 months.

Chapter 17 · AI Symptom Checkers — K Health, Ada, Buoy, Mediktor, Sensely

AI symptom checkers are the first-stage filter for telehealth entry. The patient enters symptoms before seeing a physician and receives possible diagnoses and a next-step recommendation.

K Health — See Chapter 8. Built on Maccabi data.
Ada Health (ada.com) — Founded in Berlin in 2011. One hundred million downloads across 12 countries. NHS and partial payer integration.
Buoy Health (buoyhealth.com) — Founded in Boston in 2014 by Harvard Medical School-trained physicians.
Mediktor (mediktor.com) — Founded in Barcelona in 2011. Service in 30 countries.
Sensely (sensely.com) — Founded in San Francisco in 2013. Medical avatar assistant.
Isabel Healthcare — Founded in the UK in 1999. A diagnostic decision-support service for physicians.

The limit on symptom checkers is accuracy. A 2020 BMJ study put diagnostic hit rates at 33-50 % and triage-recommendation accuracy at 55-80 % for major checkers. They are closer to a primary triage aid than a true diagnostic tool.

Since 2023, LLMs like GPT-4, Med-PaLM 2, and Claude have begun threatening the symptom checker category directly. Microsoft and Google are likely to roll out ChatGPT-style medical chatbots as integrated medical services.

Chapter 18 · AI Insurance and Eligibility Automation — Olive, Cohere Health, Notable

Next to telehealth, medical administration automation grew alongside the AI era.

Olive AI — Founded in Ohio in 2012. RPA plus AI for insurance billing and eligibility verification. Once a $4 billion-valuation unicorn, it announced a wind-down in September 2023 and sold parts of its assets to Humata Health (prior authorization automation) and Waystar.
Cohere Health (coherehealth.com) — Founded in Boston in 2019. Prior-authorization automation. Series C $50 million (2023), Series D$ 50 million (2024).
Notable (notablehealth.com) — Founded 2017. Patient intake and eligibility verification automation.
Akasa (akasa.com) — Founded 2018. Medical revenue-cycle AI.
Innovaccer (innovaccer.com) — Founded 2014. Healthcare data platform.

The Olive AI wind-down shows the difficulty of AI in healthcare. Even when the technology works, integration into the healthcare system — EMRs, payer APIs, HIPAA compliance — is extraordinarily expensive. Cohere survived by focusing on a single area (prior authorization) and locking down payer channels.

Chapter 19 · Prescription Drug Delivery — Capsule, Alto, Amazon Pharmacy, Truepill

The last mile of telehealth is drug delivery. Video visit → prescription → pharmacy → into the patient's hands. The companies integrating that flow in a single app.

Capsule (capsule.com) — Founded in NYC in 2015. Drug delivery plus pharmacist chat. Series D $300 million (2021) at a$ 650 million valuation.
Alto Pharmacy (alto.com) — Founded in San Francisco in 2015. Series E $200 million.
Amazon Pharmacy — Acquired PillPack in 2018, launched as Amazon Pharmacy in 2020, and rolled out RxPass ($5/month for Prime members) in 2023.
Truepill (truepill.com) — Founded 2016. B2B pharmacy infrastructure for telehealth companies. Used by Hims, Ro, and GoodRx.
Cost Plus Drugs (costplusdrugs.com) — Founded by Mark Cuban in 2022. Drug-price transparency. Wholesale + 15 % + pharmacist fee + shipping disclosed.

Prescription delivery is the last vertical-integration piece in telehealth. The patient should have the medication in hand within 30 minutes of the visit for the video-visit value to be complete. Hims, Ro, and Capsule are all moving in that direction.

Chapter 20 · Wearable Integration — Whoop, Oura, Apple Watch, Garmin, Dexcom

Wearables sit at the center of chronic-care and everyday health monitoring. The iter91 guide covered them separately, but here we touch on their telehealth integration.

Apple Watch — Launched 2014. ECG since Series 4 (2018). Series 9 (2023) added ECG, atrial fibrillation, body temperature, and SpO2. AFib History, Vitals, and Sleep Apnea (Series 10, 2024) followed.
Whoop — Founded 2012. Subscription model at $30/month. 24-hour heart rate, HRV, and sleep.
Oura — Founded 2013. A ring. Sleep, body temperature, HRV. Generation 4 (2024) shipped.
Garmin — Founded 1989. Exercise focused. Fenix, Venu, and Forerunner lines. Heart rate and VO2 Max.
Dexcom (NASDAQ:DXCM) — Founded 1999. Continuous glucose monitoring (CGM). G7 (2023) launched.
Abbott Libre — Abbott Diabetes Care. CGM. Libre 3 (2023).

CGM (continuous glucose monitoring) is at the core of chronic-disease management. Dexcom and Abbott Libre are reimbursed by prescription, while non-prescription lines (Lingo, Stelo, Dexcom G7) target the general consumer market.

Regulation is the biggest constraint on telehealth. Patient information, prescriptions, physician licensing, and drug delivery are all regulated.

HIPAA (US, 1996) — Privacy Rule, Security Rule, Breach Notification. The COVID-era allowance for non-HIPAA Zoom and FaceTime ended on May 11, 2023.
Korean Medical Service Act (June 2023 pilot, December 2024 amendment) — Non-face-to-face care for follow-up and chronic conditions. Drug delivery still in pilot.
Korean PIPA (Personal Information Protection Act) — Medical information is sensitive. Consent, encryption, and security obligations apply.
Japanese APPI (Personal Information Protection Act, amended 2022) — Separate protection of medical information.
Japanese online-consultation guidelines (January 2022 main provision, April 2023 online prescription) — First- and follow-up visit distinctions, restrictions on prescribed drug classes.
EU GDPR (2018) — Article 9 separate protection for medical data. The EU AI Act (2024) includes medical diagnostics and clinical decision support as high-risk AI.
DEA Ryan Haight Act (1973) + Final Rule (November 2025) — Remote prescribing of controlled substances is permanently allowed in part. ADHD Schedule II remains restricted.

Regulatory differences make market differences. The US allows free DTC telehealth but strictly regulates controlled-substance prescribing. Korea has blocked drug delivery. Japan's step-by-step expansion has been stable. The EU shoulders the GDPR burden but has consistent medical-data governance.

AI's entry into medicine has surfaced new ethical questions.

Diagnostic responsibility — If an AI symptom checker recommends a wrong diagnosis, who is responsible? The doctor? The company? The FDA?
Bias — If training data is centered on white middle-class patients, accuracy drops for Black, Latino, and Asian patients. A 2019 JAMA study showed a US medical algorithm systematically underrated Black patients.
Patient consent — When an AI scribe records a consultation, is explicit consent needed? California and Illinois are two-party-consent states.
EU AI Act — Medical AI classified as high-risk requires risk assessment, technical documentation, human oversight, and training-data governance.
FDA SaMD (Software as Medical Device) — If AI influences diagnostic or therapeutic decisions, FDA 510(k), De Novo, or PMA pathways apply.

In 2024-2025, the FDA approved about 1,000 AI/ML-based medical devices. Imaging diagnostics (chest X-ray, MRI), ECG analysis, and retinal (fundus) diagnostics are the mainstream. Clinical Decision Support AI sits under separate guidance.

Chapter 23 · Real Scenarios — Chronic, Mental Health, Primary Care, Pediatric

The 70-plus services covered in this article bundled into user scenarios.

[Scenario A — US primary care + GLP-1]
  1. User requests weight-management care in the Hims & Hers app
  2. Physician video visit → prescription
  3. Truepill / in-house pharmacy → home delivery
  4. Daily monitoring via Whoop or Apple Watch
  5. 24-hour chat support for side effects

[Scenario B — Korean chronic care (hypertension, diabetes)]
  1. Search and book a neighborhood clinic in the DoctorNow app
  2. Video or phone non-face-to-face care (chronic follow-up allowed)
  3. Prescription issued → neighborhood-pharmacy matching → quick-courier delivery
  4. Share Dexcom G7 or Abbott Libre CGM data with the doctor

[Scenario C — Japan primary care + prescription]
  1. Book a physician on Curon or CLINIC FOR
  2. Video visit
  3. Online prescription → direct pharmacy transmission
  4. Patient gets home delivery or pharmacy pickup

[Scenario D — US psychiatry + AI scribe]
  1. In-network psychiatrist match on Talkiatry
  2. Abridge records in the background during the visit
  3. Physician inserts AI note into the Epic chart in one click after the visit
  4. Prescription delivered by Capsule or Amazon Pharmacy
  5. BetterHelp or Talkspace for supplementary therapy

[Scenario E — US pediatric mental health]
  1. Adolescent ADHD care via the Brightline app
  2. Parent guardian consent → video visit
  3. ADHD meds (Schedule II) — at least one in-person visit per DEA Final Rule
  4. Coordination with school counselors and pediatricians

Each scenario uses a different mix of services. The stages where AI creates the most value are triage, note-taking, and daily monitoring. The final diagnosis and prescription decisions stay with physicians.

Chapter 24 · Economics — Where Does Telehealth ROI Come From

The economics of telehealth are measured on three axes.

Patient time saved — Average in-person visit takes 121 minutes (waiting, travel, visit) versus 25 minutes by video. But the direct dollar value to the patient is hard to measure.
Physician productivity — Patient throughput per hour rises 1.2-1.5 times for lighter cases. Complex visits are harder to convert to video.
Emergency room diversion — Primary-care telehealth cuts ER visits by 7-10 %. The core ROI for payers and employers.

Market caps of listed telehealth companies as of May 2026:

Teladoc Health (NYSE:TDOC): about $1.7 billion (down about 96 % from the 2021 peak of$ 48.2 billion)
Hims & Hers (NYSE:HIMS): about $10 billion (quadrupled in 2024-2025 on GLP-1)
Talkspace (NASDAQ:TALK): about $500 million
Amwell (NYSE:AMWL): about $200 million
Augmedix (NASDAQ:AUGX): about $100 million

Hims & Hers' surge has two drivers. (1) Compounded GLP-1, and (2) the simple revenue recognition of a DTC model that bypasses insurance. Conversely, Teladoc and Amwell are heavily dependent on payer channels, with long revenue cycles and low ARPU per patient.

Chapter 25 · Conclusion — The Next Six Years of Telehealth

2020-2026 was the explosion-and-normalization cycle for telehealth. Three big themes for the next six years (2026-2032).

AI medicine going routine — Abridge and DAX Copilot all but automate physician note-taking. ChatGPT-style medical chatbots take over primary triage. Visit time shrinks, physician throughput rises.
Integration of chronic-disease care — Telehealth, wearables, CGM, and drug delivery merge into a single app. Hims & Hers, Ro, and K Health are moving that direction.
Regulatory stabilization — After the US DEA Final Rule (November 2025), the Korean Medical Service Act amendment (December 2024), and Japanese online prescription (April 2023), a step-by-step stabilization is underway. The EU AI Act sets the governance standard for medical AI.

Telehealth claims that grew 154-fold in a single month in 2020 settled at about 38 times pre-pandemic levels in 2026 (CMS data). Remote care has not replaced in-person, but it has become the standard for medical entry and chronic-disease management.

The winners of the next six years are the firms that capture (1) AI integration depth, (2) payer and employer channel stability, and (3) the last-mile of drug delivery — all at once.

References

Teladoc Health Investor Relations: https://www.teladochealth.com/investors
American Well (Amwell) Investor Relations: https://investors.amwell.com/
Hims & Hers Investor Relations: https://investors.hims.com/
Included Health Newsroom: https://includedhealth.com/news/
Ro: https://ro.co/
K Health: https://khealth.com/
Sesame Care: https://sesamecare.com/
Talkiatry: https://www.talkiatry.com/
Cerebral DEA Settlement (DOJ press release Oct 2024): https://www.justice.gov/opa/pr
Lyra Health: https://www.lyrahealth.com/
Spring Health: https://www.springhealth.com/
Brightline: https://www.hellobrightline.com/
Talkspace Investor Relations: https://investors.talkspace.com/
BetterHelp: https://www.betterhelp.com/
Headspace Health: https://www.headspace.com/
Abridge: https://www.abridge.com/
Suki AI: https://www.suki.ai/
DeepScribe: https://www.deepscribe.ai/
Microsoft Nuance DAX Copilot: https://www.nuance.com/healthcare/dragon-ai-clinical-solutions/dax-copilot.html
Augmedix: https://www.augmedix.com/
Nabla: https://www.nabla.com/
Omada Health: https://www.omadahealth.com/
Virta Health: https://www.virtahealth.com/
Dexcom: https://www.dexcom.com/
Abbott Libre: https://www.freestyle.abbott/
DoctorNow: https://doctornow.kr/
Goodoc: https://www.goodoc.co.kr/
Ttocdoc: https://www.ttocdoc.com/
MediHere: https://medihere.co.kr/
Linkx (Doctors Mobile): https://www.linkx.co.jp/
LINE Healthcare: https://line-healthcare.com/
CLINIC FOR: https://www.clinicfor.life/
MedPeer: https://medpeer.co.jp/
Curon (MICIN): https://curon.co/
Doctolib: https://www.doctolib.fr/
KRY/Livi: https://www.livi.co.uk/
HHS HIPAA Telehealth: https://www.hhs.gov/hipaa/for-professionals/special-topics/telehealth/index.html
CMS Medicare Telehealth: https://www.cms.gov/medicare/coverage/telehealth
DEA Final Rule on Telemedicine (Nov 2025): https://www.dea.gov/press-releases
Ministry of Health and Welfare Korea Non-Face-to-Face Care: https://www.mohw.go.kr/
Japan MHLW Online Consultation: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/iryou/rinsyo/index_00010.html
EU AI Act (Official Journal): https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L_202401689
FDA Artificial Intelligence and Machine Learning (AI/ML) Software as a Medical Device: https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices

This article is current as of May 18, 2026. Telehealth pricing, features, and regulations change rapidly. Clinical decisions must always follow the judgment of physicians, pharmacists, and licensed professionals.